Published 4 years ago • loading... • Updated 4 years ago
CDC director confirms FDA in discussion to streamline authorization of omicron-specific vaccine
Summary by Ground News
The CDC director said federal regulators are in talks to fast-track the authorization process for an Omicron-specific vaccine. Dr. Rochelle Walensky said that the Food and Drug Administration was exploring whether an expedited review would be possible if a new vaccine was necessary for the variant. The new variant has spread to at least 15 states.